Free Trial
NYSE:SQZ

SQZ Biotechnologies (SQZ) Stock Price, News & Analysis

SQZ Biotechnologies logo
$0.03 0.00 (0.00%)
As of 05/30/2025

About SQZ Biotechnologies Stock (NYSE:SQZ)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.04
52-Week Range
$0.25
$3.56
Volume
N/A
Average Volume
455,220 shs
Market Capitalization
$825,748.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Receive SQZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SQZ Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

SQZ Stock News Headlines

SQZ Biotechnologies Co Ordinary Shares
Missed Nvidia? Trump’s Trade War Could Create a Bigger Winner
Missed out on Nvidia? Don’t worry — a bigger AI opportunity may be emerging right now, thanks to Trump’s newly announced tariffs. One under-the-radar U.S. semiconductor stock just gained a major edge over its foreign rivals. With demand poised to skyrocket, this chipmaker could be perfectly positioned to ride the next wave of AI growth. Shares are still flying low — but not for long.
SQZ Biotechnologies Company (SQZB)
Sqz Bio (SQZB) Earnings Dates & Reports
VC funding update: who raised money in March?
See More Headlines

SQZ Stock Analysis - Frequently Asked Questions

SQZ Biotechnologies' stock was trading at $0.03 on January 1st, 2025. Since then, SQZ shares have decreased by 6.7% and is now trading at $0.0280.
View the best growth stocks for 2025 here
.

SQZ Biotechnologies (NYSE:SQZ) posted its earnings results on Wednesday, November, 10th. The company reported ($8.00) earnings per share for the quarter, missing analysts' consensus estimates of ($5.60) by $2.40. The company had revenue of $4.76 million for the quarter, compared to analyst estimates of $11.64 million. SQZ Biotechnologies had a negative net margin of 369.96% and a negative trailing twelve-month return on equity of 119.83%.

Shares of SQZ Biotechnologies reverse split on Friday, July 7th 2023. The 1-10 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

SQZ Biotechnologies (SQZ) raised $75 million in an IPO on Friday, October 30th 2020. The company issued 4,400,000 shares at $16.00-$18.00 per share. BofA Securities and Stifel acted as the underwriters for the IPO and BTIG was co-manager.

Shares of SQZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SQZ Biotechnologies investors own include Minerva Neurosciences (NERV), Illumina (ILMN), NVIDIA (NVDA), Oramed Pharmaceuticals (ORMP), Absci (ABSI), Allogene Therapeutics (ALLO) and Beam Therapeutics (BEAM).

Company Calendar

Last Earnings
11/10/2021
Today
5/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Transportation
Current Symbol
NYSE:SQZ
Fax
N/A
Employees
1,620
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$79.46 million
Net Margins
-369.96%
Pretax Margin
-408.99%

Debt

Sales & Book Value

Annual Sales
$18.16 million
Price / Cash Flow
N/A
Book Value
$1.94 per share
Price / Book
0.01

Miscellaneous

Free Float
24,772,000
Market Cap
$825,748.00
Optionable
Not Optionable
Beta
2.34
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:SQZ) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners